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a b s t r a c t
A key event during mammalian sexual development is regression of the Müllerian ducts (MDs) in the
bipotential urogenital ridges (UGRs) of fetal males, which is caused by the expression of Müllerian
inhibiting substance (MIS) in the Sertoli cells of the differentiating testes. The paracrine signaling
mechanisms involved in MD regression are not completely understood, particularly since the receptor for
MIS, MISR2, is expressed in the mesenchyme surrounding the MD, but regression occurs in both the
epithelium and mesenchyme. Microarray analysis comparing MIS signaling competent and Misr2
knockout embryonic UGRs was performed to identify secreted factors that might be important for
MIS-mediated regression of the MD. A seven-fold increase in the expression ofWif1, an inhibitor of WNT/
β-catenin signaling, was observed in the Misr2-expressing UGRs. Whole mount in situ hybridization of
Wif1 revealed a spatial and temporal pattern of expression consistent with Misr2 during the window of
MD regression in the mesenchyme surrounding the MD epithelium that was absent in both female UGRs
and UGRs knocked out for Misr2. Knockdown of Wif1 expression in male UGRs by Wif1-speciﬁc siRNAs
beginning on embryonic day 13.5 resulted in MD retention in an organ culture assay, and exposure of
female UGRs to added recombinant human MIS induced Wif1 expression in the MD mesenchyme.
Knockdown ofWif1 led to increased expression of β-catenin and its downstream targets TCF1/LEF1 in the
MD mesenchyme and to decreased apoptosis, resulting in partial to complete retention of the MD. These
results strongly suggest that WIF1 secretion by the MD mesenchyme plays a role in MD regression in
fetal males.
& 2013 Elsevier Inc. All rights reserved.
Introduction
Sexual differentiation of the bipotential embryonic urogenital ridge
(UGR) into the testes and internal male reproductive tract is regulated
by the Sex Determining Region Y (SRY) transcription factor expressed
in XY gonads, which leads to the production of three hormones. The
fetal testes produce and secrete both Müllerian inhibiting substance
(MIS; also known as anti-Müllerian hormone, AMH), which causes
Müllerian ducts (MDs) to regress, and testosterone, which promotes
the differentiation of the Wolfﬁan ducts into the internal male
reproductive tract tissues, i.e., the epididymides, vasa deferentia, and
seminal vesicles. In the absence of MIS, as is the case with females,
MDs do not regress but continue to develop and differentiate into the
oviducts, uterus, and upper vagina (reviewed in (Teixeira et al., 2001)).
Defects in either the gene for MIS or its receptors can result in a
form of male pseudohermaphroditism characterized by retained
MD-derived tissues (Behringer et al., 1994; Mishina et al., 1996;
Jamin et al., 2002). In humans, approximately 85% of patients with
persistent Müllerian duct syndrome (PMDS) are thought to have
underlying mutations in MIS or its receptors (Belville et al., 2004;
Josso et al., 2005). The third hormone, insulin-like 3 (INSL3), is
produced by the pre-and postnatal testes and is necessary for
testicular descent (Nef and Parada, 1999; Zimmermann et al., 1999).
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As with other members of the transforming growth factor β
(TGFβ) super family, MIS binds to its speciﬁc type II receptor
(MISR2), which activates its latent kinase, causing recruitment and
phosphorylation of a type I receptor, either ACVR1 (ALK2) or
BMPR1A (ALK3), to initiate a downstream signaling cascade that
results in apoptosis and regression of the MDs (Teixeira et al.,
2001; Josso and Clemente, 2003). The MDs ﬁrst form from
coelomic epithelial cells that invaginate, proliferate, and migrate
in a cranial-to-caudal direction to merge with the urogenital sinus
epithelium (Guioli et al., 2007; Orvis and Behringer, 2007; Fujino
et al., 2009). The MDs are similarly eliminated in a cranial-to-
caudal manner as a result of MIS action (Picon, 1969; Tsuji et al.,
1992), which is attributable to the cranial-to-caudal expression of
Misr2 (Allard et al., 2000; Arango et al., 2008). We have recently
shown that Misr2-expressing cells are initially present in the
coelomic epithelium and subjacent mesenchyme of both male
and female UGRs, but that under the inﬂuence of MIS, the Misr2-
expressing cells proliferate and migrate into the mesenchyme
surrounding the male MD (Hayashi et al., 1982; Trelstad et al.,
1982; Zhan et al., 2006). We and others have also shown that
expression of the MIS type I receptors, is also spatiotemporally
controlled, and that the SMAD1, 5 and 8 subfamily of intracellular
signal transducers are involved in MD regression (Gouedard et al.,
2000; Clarke et al., 2001; Visser et al., 2001; Zhan et al., 2006;
Orvis et al., 2008). with SMAD8 being predominantly expressed
over SMAD1 and over SMAD5, which is poorly expressed during
MD regression (Clarke et al., 2001; Zhan et al., 2006) One of the
important unanswered questions in MD regression is how MISR2,
which is expressed in the mesenchyme surrounding the MD but
not in the MD epithelial cells at the time of regression (Baarends
et al., 1994; di Clemente et al., 1994; Teixeira et al., 1996), induces
apoptosis in the neighboring epithelial cells (Tsuji et al., 1992;
Catlin et al., 1997; Allard et al., 2000).
WNT/β-catenin signaling is known to be crucial for normal
uterine development from the MDs in females (Kobayashi and
Behringer 2003). For example, Wnt5a knockout mice display
anomalous development of the uterine horns, cervix and vagina,
and the uteri from Wnt7a knockout mice have defective myome-
tria, endometrial glands, and oviductal structures (Miller and
Sassoon, 1998; Parr and McMahon, 1998; Mericskay et al., 2004).
The MD mesenchyme-speciﬁc expression of Wnt5A and MD
epithelium-speciﬁc expression of Wnt7A adds further complexity
to the respective roles in uterine development (Mericskay et al.,
2004). The different phenotypes observed by the knockout of
either Wnt7a or Wnt5a suggests that these ligands have different
functional roles, which might be attributable to the separate
signaling pathways used by the respective ligands, i.e., the cano-
nical β-catenin pathway for WNT7A (Mikels and Nusse, 2006b)
and the ROR2 receptor, the Ca2þ or the planar cell polarity
pathways for WNT5A (van Amerongen et al., 2008). However,
WNT5A can also signal through the canonical β-catenin pathway,
depending on speciﬁc WNT receptor expression (He et al., 1997;
Mikels and Nusse, 2006a; van Amerongen et al., 2012).
WNT signaling is not only important for uterine development
in females, it is also a key factor in MD regression in male fetuses.
Male Wnt7a knockout mice have retained MDs (Miller and
Sassoon, 1998; Parr and McMahon, 1998), so far the only Wnt
family gene knockout reported to develop this phenotype. How-
ever, Misr2 mRNA expression is also lost in Wnt7a knockout mice,
thereby abrogating MIS signaling and precluding any inference on
its role in the downstream activity of β-catenin. Nuclear accumu-
lation of β-catenin has been reported in the MD mesenchyme cells
during MD regression (Allard et al., 2000), and male mice with
conditional knockout of β-catenin from the MD mesenchyme were
shown to have retained MDs (Kobayashi et al., 2011), indicating
that nuclear β-catenin activity in the MD mesenchyme is necessary
for MD regression. Taken together, these studies support a dual
role for WNT/β-catenin signaling in MD biology, one for regression
in males and another for differentiation in females. We have
shown that either conditional knockout of β-catenin or constitu-
tive activation of β-catenin in the MD mesenchyme leads to
myometrial pathologies in female mice (Arango et al., 2005;
Tanwar et al., 2009) and that constitutive activation of β-catenin
in the MD mesenchyme predisposes male mice to focal MD
retention (Tanwar et al., 2010). Thus, it appears that the contra-
dictory ﬁnding that MD retention in males with either β-catenin
knockout (Kobayashi et al., 2011) or constitutive activation of
β-catenin (Tanwar et al., 2010) using the same Misr2-driven Cre
would suggest that MD regression is exquisitely sensitive to WNT/
β-catenin signaling in the MD mesenchyme or that highly localized
microenvironmental factors that modulate WNT/β-catenin signal-
ing might need to act in concert with β-catenin to complete MD
regression in males. In contrast to the critical roles played byWNT/
β-catenin signaling in the MD mesenchyme, its expression in the
MD epithelium does not appear to be necessary for MD regression
(Kobayashi et al., 2011).
We have identiﬁed WNT inhibitory factor 1 (WIF1) (Hsieh et al.,
1999) as a candidate intercellular factor involved in the MIS/
MISR2-mediated regulation of MD regression using microarray
analyses of Misr2 homozygous knockout UGRs compared with
heterozygous controls. Here we show that MIS induces expression
of Wif1 mRNA during normal MD regression in males and that
knockdown of Wif1 by siRNA leads to partial retention of the MD
epithelium in UGR assays. These results suggest that the dual roles
played by β-catenin in MD retention and regression can be
controlled by the local expression of WNT inhibitors such as WIF1.
Methods
Microarray analysis of Misr2 knockout and control mice
Mice used in this study were housed under standard animal
housing conditions and maintained on a C57BL/6;129/SvEv mixed
genetic background. The Institutional Animal Care and Use Com-
mittee at Massachusetts General Hospital approved the protocols
for animal experimentations performed in this study. YFP mice (Gt
(ROSA)26Sortm1(EYFP)Cos, obtained from Dr. Frank Costantini
(Srinivas et al., 2001)) were mated with Misr2-LacZ mice
(Amhr2tm2(LacZ)Bhr, obtained from Dr. Richard Behringer (Arango
et al., 2008)) to obtain homozygous YFP/YFP;Misr2-LacZ/Misr2-LacZ
females, which were then mated with male Misr2-Cre/þ
(Amhr2tm3(cre)Bhr, obtained from Dr. Richard Behringer (Jamin
et al., 2002)) mice to produce Misr2-Cre/Misr2-LacZ;YFP/þ
embryos that are knocked out for Misr2 and cannot transduce
MIS signaling but express the YFP reporter or Misr2-LacZ/þ ;YFP/þ
embryos that can transduce MIS signaling and do not express the
YFP reporter. Genotyping was performed when necessary with
DNA collected from tail biopsies using standard PCR protocols.
Timed pregnant matings were performed, and the presence of a
vaginal plug in the morning was considered embryonic day 0.5
(E0.5) at 12 p.m. UGRs of the male embryos were sorted manually
by YFP ﬂuorescence (YFPþ were Misr2 knockouts, YFP were
Misr2 heterozygotes) using a ﬂuorescence dissecting microscope,
and the mesonephroi were dissected away from the gonads with a
scalpel as cleanly as possible, pooled, frozen and stored at 80 1C.
Female UGRs were discarded. Total RNA was prepared (5 mg)
from approximately 200 mesonephroi for each genotype, the
mRNA converted to cRNA, and compared by microarray analyses
using the Affymetrix oligonucleotide chips (Mouse430_2) at the
Harvard/Partners Center for Personalized Genetic Medicine. Data
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from the microarray analysis has been deposited in the GEO
database under the accession number GSE38009.
Animals, organ culture and recombinant human MIS
UGRs were dissected fromwildtype embryos of timed pregnant
mice and studied at developmental stages E12.5, E13.5 and E14.5,
to determine normal gene expression patterns and morphological
changes in vivo. UGRs collected from timed pregnant mice at E13.5
were also dissected and then cultured on MilliCell-CM membrane
(Millipore, Bellerica, MA) over 2% agarose gel droplets immersed in
CMRL 1066 medium (Life Technologies, Grand Island, NY) supple-
mented with 10% female fetal bovine serum (Aires Scientiﬁc/Bio-
logos, Richardson, Texas) to avoid bovine MIS in male serum,
100 U/ml penicillin, 100 mg/ml streptomycin, and 10 nM testoster-
one, which stimulates Wolfﬁan duct development, for comparison
with MDs. Cultures were carried out with or without recombinant
human MIS (rhMIS) at a ﬁnal concentration of 6 mg/ml (42.5 nM).
MIS was puriﬁed from serum-containing media of Chinese ham-
ster ovary clonal cells expressing native MIS by immunoafﬁnity
chromatography as described previously (Ragin et al., 1992).
RNA probes
Digoxigenin-labeled antisense and sense riboprobes were gen-
erated by in vitro transcription using digoxigenin-labeled nucleo-
tide mix (Roche, Indianapolis, IN) according to the manufacturer0s
instructions. A PCR fragment of Wnt7a coding sequence (NM_00-
9527; nucleotides 335-970) was subcloned into pCRII-TOPO (Life
Technologies), digested with EcoRV, and transcribed with Sp6 RNA
polymerase to make antisense probes. A PCR fragment of coding
sequence of Wif1 (NM_011915; nucleotides 516-1131) was cloned
from a mouse testis cDNA library into pCR2.1-TOPO (Life Technol-
ogies), digested with SpeI, and transcribed with T7 RNA polymer-
ase to make antisense probes. The Mis plasmid (Swain et al., 1998)
was digested with SmaI and transcribed with T7 RNA polymerase
for the antisense probe. The probe for Misr2 was made as
previously described (Clarke et al., 2001). All templates were
puriﬁed using phenol–chloroform–isoamyl alcohol and ether for
RNase-free conditions.
In situ hybridization
Immediately following dissection at various gestational ages or
after organ culture in RNase-free conditions, UGRs were ﬁxed for
2 h at 4 1C in 4% paraformaldehyde (PFA). The UGRs were dehy-
drated and stored in 100% methanol until further use. Tissues were
rehydrated, treated with hydrogen peroxide, then with 10 g/ml
proteinase K, pre-hybridized, and hybridized with digoxigenin-
labeled sense or antisense riboprobes overnight at 70 1C. A mini-
mum of 3 UGRs was used for each experimental condition. After
high-stringency washing, the samples were placed in 10% sheep
serum/TBS-T for 1.5 h at room temperature for blocking, then
incubated with anti-digoxigenin-AP antibody (Roche) at 1:2000
overnight at 4 1C with gentle rocking. The signals were visualized
using the BM-Purple alkaline phosphatase substrate (Roche). For
frozen sections, samples were embedded in O.C.T. compound and
subsequently cryosectioned at 16 mm. Photos were taken with a
Nikon SMZ1500 dissecting microscope with a Spot digital camera
(Diagnostic Instruments, Sterling Heights, MI).
RNAi in organ culture
A cocktail of siRNA duplex oligoribonucleotides of Wif1
(MSS280614, MSS280615, MSS280616) and negative control
duplexes were purchased from Life Technologies. RNAi in organ
culture was performed as described previously (Zhan et al., 2006).
siRNA concentrations between 50 and 400 nM were tested with
murine embryonal ﬁbroblasts using the Alexa Fluor-555 siRNA
control (Life Technologies) for optimal silencing efﬁciency and
minimal toxicity; as a result, 200 nM was selected for further
studies. UGRs from E13.25 were transfected with siRNA duplex in
serum-free culture medium by using the Oligofectamine RNAiMAX
reagent (Life Technologies). siRNAs and Oligofectamine were
diluted in separate tubes in OptiMEM (Life Technologies), com-
bined and incubated for 20 min at room temperature. The siRNA:
Oligofectamine mixture was added to the medium and incubated
with immersed UGRs for 12 h. The UGRs were subsequently placed
on MilliCell-CM membranes to continue culture for an additional
60 h at the air-media interface over complete medium. The tissues
were then ﬁxed in 4% PFA for either whole mount in situ
hybridization or immunoﬂuorescence staining.
Immunoﬂuorescence staining following Wif1 siRNA treatment of
UGRs
For immunoﬂuorescence staining, UGRs were incubated in 15%
sucrose solution for 2 h followed by embedding in 7.5% gelatin/15%
sucrose. The embedded tissues were frozen at 60 1C in isopen-
tane and sectioned at 9 mm. For β-catenin, TCF1 and LEF1 immu-
nostaining, serial sections were washed in PBS three times
consecutively. Sections were then washed in PBST and blocked
with 10% donkey serum, 1% bovine serum albumin, and 0.1%
triton-X in PBS for β-catenin or 5% goat serum and 0.1% triton-X
for TCF1/LEF1 in TBST, 1 h at room temperature. Tissue sections
were then incubated in a humidiﬁed chamber overnight at 4 1C
with anti-β-catenin primary antibody (1:250; BD Transduction
Laboratories, San Jose, CA), anti-TCF1 and anti-LEF1 primary
antibodies (1:500; Cell signaling Technologies, Danvers, MA).
Tissue sections were subsequently washed with PBS-T, incubated
for 1 h at room temperature with AlexaFluor secondary antibodies
(1:250; Life Technologies), then counterstained with 40,60-diami-
dino-2-phenylindole (DAPI). Images were photographed using a
microscope (Nikon Eclipse TE 2000-S) equipped with a Spot digital
camera.
TUNEL assay
After transfecting E13.5 male UGRs with Wif1 siRNA and RNAi
for 12 h, they were incubated for an additional 48 h in complete
medium. The UGRs were ﬁxed in 4% PFA at 4 1C for 2 h, washed in
PBS and kept at 4 1C for immediate assay or stored in 70% ethanol
at 4 1C for later analysis. The UGRs were post ﬁxed in cold ethanol:
acetic acid at a 2:1 ratio for 5 min at 20 1C for permeabilization.
Terminal deoxynucleotidyl transferase enzyme and anti-dig-
oxigenin conjugates were applied according to the ApopTag Plus
Fluorescein In Situ kit (Millipore) manufacturer0s protocol. Coun-
terstaining was performed with DAPI, and the UGRs were exam-
ined with a dissecting microscope. Discrete TUNELþ cells lining
the Müllerian duct were manually counted in photos of long-
itudinal planes obtained after identifying the section where the
Müllerian duct was present along with sections approximately
100 mm above and below. As a result, 3 sections per ridge for
5 control ridges and 6 Wif1 siRNA treated ridges were counted.
Statistical analysis
Results are expressed as mean values7standard error of mean
(SEM) from a minimum of three individual experiments. Statistical
analyses were perfomed by ANOVA or unpaired t-test as appro-
priate with Prism 5 (GraphPad, La Jolla, CA). P-valuesr0.05 were
considered statistically signiﬁcant.
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Results
MIS induces Wif1 expression in the MD mesenchyme
The MIS ligand will not be able to bind to MD mesenchyme
cells lacking the MISR2 receptor and initiate the signaling cascade
required for MD regression. To determine which genes are induced
by MIS signaling during MD regression, a mating scheme was
developed for efﬁcient sorting of heterozygous Misr2 UGRs from
homozygous Misr2 knockout UGRs of E14.5 fetuses without
resorting to PCR genotyping (Fig. 1A). The male gonads were
dissected away from the UGRs so that only the duct-containing
mesonephroi were collected and pooled for total RNA isolation
enriched for agonadal mRNAs. The results of microarray analyses
of the RNAs from Misr2-expressing UGRs compared to the Misr2
knockout UGRs are shown in Tables 1 and 2. The loss of Misr2
expression in the knockout RNA (not shown) was used to validate
the ability of the experiment to differentiate between Misr2
knockout and heterozygous UGRs.
Wif1 mRNA expression was induced more than 7-fold in MIS-
responsive agonadal UGRs (Table 1). WIF1 belongs to the secreted
Frizzled-related protein class of WNT signaling inhibitors that
binds to WNTs, which in turn inhibits their binding to their
receptors (Hsieh et al., 1999). Its expression and activity have been
reported in a variety of different developmental pathways that,
when disrupted, can lead to developmental anomalies and cancer
(Kawano and Kypta 2003). Because of the importance of WNT
signaling for MD differentiation and regression, we performed
whole-mount in situ hybridization to verify the induction of Wif1
mRNA by MIS. UGRs were collected from E13.5 embryos of the
Misr2 knockout and heterozygous embryos. E13.5 was chosen
Fig. 1. Wif1 expression is diminished with loss of MIS signaling in UGRs. (A) Schematic showing the breeding and scoring used to distinguish UGRs from Misr2 knockout
mice and heterozygous mice. Misr2 knockout UGRs have both the Misr2-Cre and Misr2-LacZ alleles. The Cre recombinase from the Misr2-Cre allele drives YFP expression,
which is detected by ﬂuorescence. The Misr2-Cre allele is not in the heterozygotes and YFP expression is not detected. Whole mount in situ hybridization for Wif1 mRNA in
male UGRs from embryonic day 13.5 Misr2 knockout mice (B) displays downregulation of Wif1 as indicated by BM purple compared to Misr2 heterozygous control (C) and
wildtype (D) UGRs, where there is a clear expression along the MD as well as in the gonads. (E) NoWif1mRNA expression is detected with a sense RNA probe. Frozen sections
of the whole mount in situ hybridized UGRs reveal noticeably higher levels ofWif1mRNA detection in the mesenchyme surrounding the MD epithelium of the heterozygous
and the wildtype controls ((G) and (H), respectively) than in the Misr2 knockout (F) or in the sense control (I). Arrowheads indicate MDs in whole mounts. MD epithelium is
outlined with a dashed line in panels with sections. T¼testis, M¼Müllerian duct, W¼Wolfﬁan duct. Bar¼100 μm.
Table 1
Genes upregulated with MIS signaling.
Gene name Accession Fold
Sp6 NM_031183.2 7.715
Wif1 NM_011915.2 7.36
Msx2 NM_013601.2 6.688
Dlx5 NM_010056.2 4.069
Gata5 NM_008093.2 3.939
Ednrb NM_007904.4 3.633
Ablim3 NM_198649.3 3.503
Ncstn NM_021607.3 3.451
Ddx17 NM_199080.2 3.33
Syt1 NM_009306.3 3.273
H2-T23 NM_010398.1 3.219
Mbp NM_010777.3 3.023
Mael NM_175296.4 2.977
Stk31 NM_029916.2 2.951
Dppa4 NM_028610.2 2.937
Rpl39l NM_026594.2 2.914
Pou5f1 NM_013633.3 2.893
Zmat2 NM_025594.3 2.867
Nfatc1 NM_016791 2.76
Helb NM_080446.2 2.751
Dazl NM_010021.5 2.7
Gfra2 NM_008115.2 2.658
Epha4 NM_007936.3 2.634
Ptprd NM_011211.3 2.576
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because MD regression is well underway by E14.5, when it is more
difﬁcult to detect the MDs in males. Expression of Wif1 mRNA was
clearly visible along the entire length of the MD and in the testis
cords of bothMisr2wild type and heterozygous UGRs (Fig. 1C and D).
In Misr2 knockout UGRs, only trace expression of Wif1 was observed
(Fig. 1B) when stained for an equivalent amount of time as Misr2-
expressing UGRs but which was still higher than that observed with
a negative control sense probe (Fig. 1E). Analyses of the whole-mount
UGRs in frozen sections were done to determine the spatial relation-
ship ofWif1 mRNA expression with respect to the MD epithelium. In
theMisr2wild type and heterozygous UGRs, expressionwas localized
to the mesenchyme surrounding the MD epithelium (Fig. 1G and H)
where Misr2 is expressed and to the MD epithelial cells as well.
However, the sections from the Misr2 knockout UGR showed what
little Wif1 mRNA was observed localized to the MD epithelial cells
(Fig. 1F).
The expression pattern of Wif1 mRNA over time was studied by
whole mount in situ hybridization in male UGRs from E12.5, E13.5
and E14.5 embryos. At E12.5 Wif1 mRNA expression is essentially
negative (Fig. 2A) and frozen section analysis shows that the light
staining in the duct could be an artifact of substrate pooling in the
MD lumen (Fig. 2D). However at E13.5 male UGRs are strongly
positive for Wif1 in the mesenchyme surrounding the MD epithe-
lium, particularly at the cranial end (Fig. 2B and E). In contrast,
female UGRs at this age do not show Wif1 expression by whole
mount in situ hybridization above background (Fig. 2H and I). As
MD regression progresses caudally at E14.5, Wif1 expression was
observed at the middle to caudal end of the MD where regression
has not yet occurred (Fig. 2C and G). At the cranial end where MD
regression has occurred, Wif1 expression is not observed (Fig. 2C
and F). In addition to MIS, the embryonic male gonads produce
testosterone, which is necessary for Wolfﬁan duct development
and has been shown to induce Wif1 expression (Keil et al., 2012),
and other secreted factors that could account for induced Wif1
expression in MD mesenchyme in male UGRs compared with
females. To ensure that Wif1 expression is induced by MIS alone,
without the need for any other factor produced by the fetal male
gonads, E13.5 female UGRs were exposed to recombinant human
MIS (6 μg/ml) for 48 h and then analyzed by whole mount in situ
Table 2
Genes downregulated with MIS signaling.
Gene name Accession Fold
Fbxo10 NM_001024142.1 2.744
Phip NM_001081216.1 2.764
Cnn3 NM_028044.2 2.944
Spry4 NM_011898.2 3.112
Hspa14 NM_015765.2 3.21
Bcas2 NM_026602.3 3.405
Kif1c NM_153103.2 4.155
Tfap2c NM_009335.2 4.37
Kif5b NM_008448.3 4.406
Mat2a NM_145569.4 6.663
Fank1 NM_025850.2 8.488
Fig. 2. MIS induces Wif1 expression. Time course analysis shows expression of Wif1 mRNA by in situ hybridization in male UGRs at E12.5 (A), E13.5 (B) and E14.5 (C).
Corresponding frozen sections ((D) and (E)) show strongest Wif1 mRNA expression is detected in the MD mesenchyme at E13.5. At E14.5, Wif1 mRNA is not detectable in
rostral sections where the MDs have regressed ((C) and (F)) but more caudal expression is observed where the MD has not yet regressed ((C) and (G)).Wif1mRNA expression
is low or not detectable in female UGR at E13.5 ((H) and (I)). In contrast, Wif1 mRNA is detected in the surrounding mesenchyme of the MDs (arrowhead) in E13.5 female
UGRs exposed to rhMIS for 60 h in organ culture ((J) and (K)). M¼Müllerian duct, W¼Wolfﬁan duct. MD epithelium is outlined with a dashed line in panels with sections.
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Fig. 3. Wif1mRNA knockdown inhibits MD regression. E13.5 male UGRs were treated with either control scrambled siRNA duplexes or with a cocktail ofWif1 siRNA duplexes
for 12 h and assayed for MD regression after 60 h by whole mount in situ for Wnt7a, a MD epithelium-speciﬁc mRNA. (A) The absence of Wnt7a in most of the MD
epithelium indicates nearly complete regression of the MDs was observed in most UGRs with control siRNA. (B) Complete MD regression was not observed in UGRs
transfected with Wif1 siRNA. Higher magniﬁcation of representative UGRs boxed in (A) and (B) are shown in (C)–(F). Black arrowheads indicate the Wolfﬁan duct and red
arrowheads indicate Wnt7a-postiive MDs. UGRs from three separate sets of experiments were scored for MD retention for semi-quantitative comparison with the UGRs
divided into rostral, middle and caudal segments (G). Open circles (○) are male control siRNA-treated UGRs, and closed circles () are Wif1 siRNA-treated UGRs showing
signiﬁcantly fewer MD regression in all three segments analyzed. Neither Mis in the testes nor Misr2 mRNAs in the testes and remaining MD appeared to be affected by
transfection with Wif1 siRNA ((J) and (K)) compared to controls ((H) and (I)). Arrowhead indicates remaining MD with Misr2 mRNA. T¼testis.
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hybridization for Wif1 mRNA. Partial MD regression was observed
in female UGRs (Fig. 2J), which like male UGRs express theMisr2 in
the MD mesenchyme (Baarends et al., 1994; di Clemente et al.,
1994; Teixeira et al., 1996), precluding continued expression of
Wif1 as was observed in male UGRs with MD regression (Fig. 2C).
Also as with male UGRs (Fig. 2G), analysis of frozen sections where
MD regression was not complete showed expression of Wif1 in
female UGRs exposed to MIS (Fig. 2K). These results clearly
demonstrate the transitory nature of Wif1 expression in a cranial to
caudal manner within a narrow window of time in the MD
mesenchyme during male UGR development that is induced by MIS.
Wif1 knockdown inhibits complete MD regression in vitro
To determine whether MD regression in vitro is dependent on
MIS-induced expression of Wif1, knockdown of Wif1 was per-
formed with a cocktail of Wif1-speciﬁc siRNA in UGRs from E13.25
male embryos in organ culture. When the UGRs were treated with
negative control siRNA, complete or near complete regression of
the MDs was observed in the UGRs by whole mount in situ
hybridization for Wnt7a mRNA (Fig. 3A), which is speciﬁc to the
MD epithelium (Miller and Sassoon, 1998; Parr and McMahon,
1998). Occasional MD epithelium was detected, usually in the
Fig. 4. Downstream activities of β-catenin are induced byWif1 knockdown. Expression of β-catenin ((A) and (B)) and its regulated genes, TCF1 ((C) and (D)) and LEF1 ((E) and
(F)), were analyzed by immunoﬂuorescence in frozen sections in either control siRNA-treated orWif1 siRNA-treated E13.5 male UGRs at 60 h post transfection. The degree of
apoptosis in the MD was analyzed by determining the number of TUNEL-positive cells located mostly at the rostral tip (arrowhead) of the UGRs treated with either control
siRNA (G) or with Wif1 siRNA (I). White boxed areas in (G) and (I) are shown at higher magniﬁcation in (H) and (J). M¼MD, W¼Wolfﬁan duct, T¼testis. MD epithelium is
outlined with a dashed line. Nuclei are stained with DAPI. Bar¼100 μm.
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caudal end, which regresses last (Picon, 1969; Tsuji et al., 1992).
The whole mount in situ hybridizations clearly demonstrate
regression of the MD as reﬂected by the absence or reduced level
of staining for Wnt7a (Fig. 3C and D). In contrast, when the UGRs
were exposed to a cocktail of Wif1-speciﬁc siRNAs, signiﬁcant
retention of the MDs was observed (Fig. 3B). In some UGRs, Wnt7a
expression was observed along the whole length of the MD
(Fig. 3E), but in others caudal expression was most prominent
(Fig. 3F). After arbitrarily dividing the MD into three vertical
segments, a quantitative comparison of the rate of MD retention
between the control and Wif1 siRNA-treated UGRs revealed a
statistically signiﬁcant difference (Fig. 3G) in each segment, con-
ﬁrming that knockdown ofWif1 expression negatively impacts MD
regression.
To rule out the possibility that MD retention might be due to an
indirect effect of Wif1 siRNA knockdown on the expression of
either Mis or Misr2, the experiment was repeated and the URGs
were examined by whole mount in situ hybridization with probes
speciﬁc for Mis and Misr2. Neither Mis (Fig. 3H and J) nor Misr2
(Fig. 3I and K) mRNA expression in the gonads appeared to be
affected in the Wif1 siRNA-treated UGRs compared to controls.
Misr2 expression in the MD mesenchyme, while limited to the
caudal regions in the control-treated UGRs undergoing regression,
was also observed in the retained MD regions of the Wif1 siRNA-
treated UGRs. In the face of MD regression in controls, changes in
Misr2 expression are more difﬁcult to interpret in the Wif1
knockdown UGRs because its expression is observed as an artifact
of MD retention.
We next examined WNT/β-catenin signaling in control and
Wif1 knockdown male UGRs before MD regression is normally
completed. Although membranous β-catenin was observed in the
control UGRs, increased β-catenin signal was observed in both the
mesenchymal cells surrounding the MD and the MD epithelial
cells of Wif1 siRNA-treated UGRs (Fig. 4A and B). Conﬁrmation of
increased nuclear β-catenin activity with Wif1 siRNA was observed
by strongly increased expression of LEF1 (Fig. 4C and D) and a
more subtle increase in TCF expression (Fig. 4E and F). However,
the induction of both these β-catenin-regulated genes appeared
limited to the MD mesenchyme cells, suggesting that the increased
β-catenin expression resulting from Wif1 knockdown was not
affecting nuclear β-catenin activity in the MD epithelial cells.
These results would also suggest that during normal MD regres-
sion, MIS-induced WIF1 suppresses WNT/β-catenin signaling in
the MD mesenchyme by an autocrine mechanism.
Because MIS-induced apoptosis in the Müllerian duct epithe-
lium is a key phenotypical event in male MD regression, the
impact of knocking down Wif1 mRNA on apoptosis was investi-
gated. TUNEL staining for UGRs after Wif1 siRNA (Fig. 4G and H)
versus negative control siRNA treatment (Fig. 4I and J) revealed a
signiﬁcantly increased distribution of apoptotic cells along the
cranial portion of the ridges in the control siRNA treated UGRs
(mean 21179 SEM vs. 3273 SEM; p¼0.0009) at 60 h post transfec-
tion, conﬁrming that induced WNT signaling negatively affects MD
regression.
Discussion
The development of the male or female sex phenotype from the
bipotential embryonic gonads has fascinated reproductive biolo-
gists for nearly a century. Aside from its inherent allure, it is also
important to understand sex differentiation because genitourinary
disorders are the most common in human development and of
signiﬁcant clinical importance to human health and quality of life.
These include congenital uterine anomalies, cryptorchidism, inter-
sex anomalies, hypospadias, and exstrophies, which are currently
treated by surgical intervention, and in some cases combined with
hormonal therapy, with varying degrees of success. Thus, the basic
developmental mechanisms underlying gonadal and reproductive
tract development have to be further investigated in order to
understand more fully the underlying etiologies of these genitour-
inary anomalies with the goal of developing better and more
rational methods to treat these patients. For example, the basic
mechanisms and the complex coordination of regression, reten-
tion and selective differentiation of the Müllerian and Wolfﬁan
ducts are not completely understood. Our results reported here
showing that inhibition of WNT signaling in male UGRs after MIS
binds to its receptor, MISR2, in the MD mesenchyme provide an
important contribution to the study of the key mechanisms
governing the regression of MD epithelial cells.
We show that inducing WNT signaling by blocking MIS-
mediated induction of Wif1 with subsequent accumulation of
β-catenin can result in partial MD retention and support our
previous ﬁndings that male mice with constitutively activated
β-catenin in the MD mesenchyme have a focal MD retention
phenotype (Tanwar et al., 2010). Conversely, another report using
the same Misr2-Cre allele indicated that β-catenin in the MD
mesenchyme is required for regression (Kobayashi et al., 2011),
supporting a previous study that suggested accumulation of
β-catenin was required for MD regression (Allard et al., 2000). Taken
together, these studies suggest an intricately regulated balance of
WNT/β-catenin signaling may be crucial for normal regression of MD
in males and that too much or too little β-catenin activity might
in fact interfere with MD regression (Tanwar et al., 2010).
A similar phenomenon has been observed during lung development,
where altering the dosage of β-catenin activity in vivo by knockout
or constitutively activated expression can have profound effects on
epithelial cell differentiation (Mucenski et al., 2003, 2005; Okubo
and Hogan, 2004). Another possibility is that inhibition of Wif1
expression might be affecting WNT signaling pathways that do not
involve canonical β-catenin activity, but rather those that involve the
planar cell or Ca2+ pathways, or even the orphan receptor tyrosine
kinase, ROR2, an important mechanism required for WNT5A-driven
alveolarization in the lung (Loscertales et al., 2008).
A key ﬁnding from our studies shown in Fig. 4, suggests that
decreased Wif1 expression (i.e., more WNT signaling) appears to
increase cellular β-catenin levels in both the MD epithelial cells
and in the surrounding mesenchymal cells but induced nuclear
expression of the proteins encoded by the WNT target genes, Lef1
and Tcf1, was only observed in the mesenchymal cells. Although
Wif1 expression appears to be limited to the MD mesenchyme, it is
a secreted factor that binds to WNT proteins and inhibits their
binding to cell surface receptors, and subsequent intracellular
paracrine WNT signaling in both the mesenchyme and adjacent
epithelium. These results support the observation that LEF1
expression is observed in the mesenchyme of β-catenin intact
UGRs but not in β-catenin knockout UGRs (Kobayashi et al., 2011).
We speculate that the effects of WIF1 on canonical β-catenin
activity appear to be autocrine. These results do not preclude a
paracrine function for WIF1 in the epithelium but do suggest that
if there is one, it probably does not require β-catenin-mediated
transcriptional activation.
In addition toWif1, our analyses comparingMisr2 heterozygous
with Misr2 knockout UGRs showed that the expression of many
other genes was changed by loss of MIS signaling (GSE38009). We
choseWif1 for further analyses because of our interest in β-catenin
signaling during Müllerian duct differentiation. Msx2 and Dlx5 are
two other genes highly induced by MIS signaling in the UGRs that we
expect to study further. The induction ofMsx2, a homeobox gene that
encodes the muscle segment homeobox homolog 2 protein, in the
male MDs during regression has been previously shown in chicken
embryos (Ha et al., 2008). Although loss of Msx2 has pleiotropic
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effects in mice, it does not appear to affect fertility (Satokata et al.,
2000), which would be expected in males with retained MDs
(Mishina et al., 1996). However, its loss does appear to exacerbate
the deleterious effect of diethylstilbestrol on Müllerian duct devel-
opment (Yin et al., 2006) and conditional postnatal knockout of both
Msx1 and Msx2 leads to defective uterine implantation (Daikoku
et al., 2011). Dlx5, another homeobox gene that encodes Distal-less
homeobox 5 protein, has been implicated in craniofacial, limb, and
bone development (Kraus and Lufkin, 2006), but there are no reports
linking Dlx5 to MD development or regression.
We examined whether evidence of MD retention could be
observed in both neonatal and 4 week old male Wif1 / mice
(Kansara et al., 2009) but did not observe any MD-derived tissues in
these mice (data not shown). TheWif1 / mice have yet to provide
an overt phenotype other than an increased susceptibility to develop
osteosarcomas, which is very surprising given the number of diverse
processes that WIF1 has been implicated in modulating, including
lung development (Xu et al., 2011), hematopoiesis (Schaniel et al.,
2011), and carcinogenesis (Ramachandran et al., 2012). A recent
report showed that Wif1 expression in the mesenchyme of the
urogenital sinus is regulated by androgens and that it enhances
prostatic development (Keil et al., 2012). However, they also reported
no obvious prostate phenotype was observed in the Wif1 / mice
as well. The disparity between the results from the knockdown organ
culture experiments shown in Fig. 3 and the absent Wif / knock-
out mouse phenotype is reminiscent of an earlier report showing
that, although knockdown of matrix metalloproteinase 2 (MMP2)
inhibited MD regression in organ culture, the Mmp2 / male mice
did not have retained MD tissues (Roberts et al., 2002). Those authors
speculated that functional redundancy of the MMP family could be
mitigating the loss of MMP2 on UGR development in vivo, which
could also be an issue in the Wif1 / mice with the several other
WNT inhibitors available to replace some WIF1 function. Resolution
of these discrepancies with the numerous critical activities attributed
WIF1 and the lack of a Wif1 / phenotype is eagerly awaited.
In summary, we have reported gene expression analyses of
murine UGRs during MD regression with and without MIS signal-
ing in order to understand the mechanisms driving a fundamental
aspect of sexual differentiation. We chose Wif1 for follow up
studies and showed for the ﬁrst time that MIS induces the
expression of the Wif1 gene, which encodes an inhibitor of WNT
signaling. Conﬁrmatory studies showed that knockdown of Wif1
mRNA expression interferes with MD regression. Like the role of β-
catenin itself during MD regression, we hypothesize that an
exquisitely tuned amount of Wif1 expression is required for
normal reproductive tract development.
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